Showing results (1-10 of 35) with videos related to
Sort By:
Pageof 4
Brain Research|July 11, 1994
The MAO-B inhibitor deprenyl, but not the MAO-A inhibitor clorgyline, potentiates the neurotoxicity of p-chloroamphetamineS Benmansour, D J BrunswickProceedings of the National Academy of Sciences of the United States of America|August 1, 1971
Photo-affinity labels for adenosine 3':5'-cyclic monophosphateD J Brunswick, B S CoopermanJournal of Neurochemistry|July 1, 1985
High- and low-affinity binding components for [3H]imipramine in rat cerebral cortexP G Conway, D J BrunswickLife Sciences|August 24, 1987
Structural derivatives of pindolol: relationship between in vivo and in vitro potencies for their interaction with central beta-adrenergic receptorsS M Tejani-Butt, D J BrunswickJournal of Medicinal Chemistry|August 1, 1986
Synthesis and beta-adrenergic receptor blocking potency of 1-(substituted amino)-3-(4-indolyloxy)propan-2-olsS M Tejani-Butt, D J BrunswickThe Journal of Clinical Psychiatry|March 1, 1979
High dose desipramine, plasma drug levels and clinical responseJ Amsterdam, D J Brunswick, J MendelsBritish Journal of Clinical Pharmacology|April 1, 1979
Specific radioimmunoassay of amitriptyline and nortriptylineD J Brunswick, B Needelman, J MendelsThe Journal of Pharmacology and Experimental Therapeutics|September 1, 1982
Effect of treatment of rats with antidepressants on melatonin concentrations in the pineal gland and serumW E Heydorn, D J Brunswick, A FrazerThe Journal of Pharmacology and Experimental Therapeutics|October 1, 1985
Labeling in vivo of beta adrenergic receptors in the central nervous system of the rat after administration of [125I] iodopindololL Tondo, P G Conway, D J BrunswickThe Journal of Clinical Psychiatry|June 1, 1980
Reliability of commercially available tricyclic antidepressant levelsJ D Amsterdam, D J Brunswick, J MendelsPageof 4